Philadelphia, PAMarietta Daily Journal

Full FDA approval of COVID-19 vaccines might lead more people to get them. What’s the holdup?

PHILADELPHIA — More than eight months ago, large studies found that both the Pfizer-BioNTech and Moderna COVID-19 vaccines reduced the risk of illness by more than 90%. Yet the U.S. Food and Drug Administration has not yet granted them full approval, to the dismay of public-health officials eager to boost vaccination rates as the delta variant sends infections skyward.
Picture for Full FDA approval of COVID-19 vaccines might lead more people to get them. What’s the holdup?

Delta Variant Dangers: Mixing And Matching Covid Vaccines

The Delta covid variant is all over the news, and it became the most dominant one around the world according to the latest expert opinions. The Delta Covid variant is ruling all the other strains across the globe these days. It’s been already revealed that the Delta variant is the most dangerous one so far, according to more expert opinions across the globe.
Picture for Delta Variant Dangers: Mixing And Matching Covid Vaccines
Medical & Biotechbeckershospitalreview.com

BioNTech developing mRNA vaccine for malaria

BioNTech, the German biotech that partnered with Pfizer to develop the first COVID-19 vaccine to earn the FDA's emergency use authorization, is now using mRNA to tackle another disease: malaria. The biotech plans to start testing its malaria vaccine in clinical trials by the end of 2022, according to a...
Picture for BioNTech developing mRNA vaccine for malaria
Pasadena, TXsanjac.edu

Once needle-phobic, pharmacy tech alumna now giving COVID-19 vaccines

Could she give shots? Adilene Ambriz Ayala was choosing between becoming a pharmacy technician or a nurse, and that question made the decision easy. “I was scared of needles,” Ambriz said. Today, the San Jacinto College pharmacy technician alumna fills prescription behind a Walgreens pharmacy counter. But this spring, the...
SciencePosted by
610 Sports Radio

COVID immunity may dwindle after 7 months, per newest data

New evidence is showing that the protection the COVID-19 vaccines provide may be declining as the Delta variant continues to spread rapidly. BioNTech CEO Ugur Sahin told the Wall Street Journal that people who were fully vaccinated in January with the Pfizer shot are seeing immunity levels start to drop seven months later.
Medical & Biotechlexblog.com

Next Up for BioNTech: Malaria

MRNA pioneer BioNTech announced recently that it is developing an mRNA-based vaccine to attempt to eradicate malaria. Its efforts are geographically focused on Africa, and the company said it is furthering those efforts to build manufacturing capacity on the African continent. This all comes on the heels of being the...

Biontech wants to develop mRNA-based malaria vaccine

Mainz-based pharmaceutical company Biontech plans to develop the world's first malaria vaccine based on mRNA technology. "Together, we are doing everything we can to develop a safe and effective mRNA-based malaria vaccine," Ugur Sahin, co-founder of Biontech, said Monday. "It is designed to prevent the disease, reduce mortality and provide...
Medical & Biotechgetnewsalert.com

BioNTech plans to use mRNA technology to develop malaria vaccine

German biotechnology company, BioNTech has announced plans to use mRNA technology that is currently used to produce its coronavirus vaccine for developing malaria treatment. BioNTech that produced its first globally approved coronavirus vaccine with U.S. partner Pfizer intends to initiate clinical trials for a safe and highly efficient malaria vaccine by next year.
Medical & Biotechpncguam.com

8 new cases of COVID-19 out of 518 tested

Eight (8) new cases of COVID-19 were identified out of 518 tests performed on July 26. To date, there have been a total of 8,514 officially reported cases of COVID-19 with 143 deaths, 52 cases in active isolation, and 8,319 not in active isolation. The CAR Score is 0.3. Operation...

After Covid jab, BioNTech to start trialling malaria vaccine next year

INTERNATIONAL NEWS - Germany’s BioNTech, which developed a coronavirus vaccine with US giant Pfizer in record time, said Monday it aimed to start trialling a malaria vaccine next year using the same breakthrough mRNA technology. If successful, the vaccine could be a crucial step in the fight against the mosquito-borne...